Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Early research (Phase 1)Study completedNCT00030095
What this trial is testing

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT03311477
What this trial is testing

Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 9
Testing effectiveness (Phase 2)Study completedNCT03220854
What this trial is testing

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Who this might be right for
Solid Tumor
Virginia Commonwealth University 5
Testing effectiveness (Phase 2)UnknownNCT04179656
What this trial is testing

The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor

Who this might be right for
Solid TumorHER2 Gene MutationHER-2 Gene Amplification+1 more
Tianjin Medical University Second Hospital 100
Early research (Phase 1)Study completedNCT00389922
What this trial is testing

Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07061639
What this trial is testing

QLS5133 Monotherapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 212
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Early research (Phase 1)Study completedNCT01293630
What this trial is testing

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sanofi 18
Testing effectiveness (Phase 2)Ended earlyNCT05580770
What this trial is testing

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888831
What this trial is testing

BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 100
Early research (Phase 1)UnknownNCT04471675
What this trial is testing

Evaluation of the Safety and Efficacy of Albumin-bound Docetaxel

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714395
What this trial is testing

Evaluate Preliminary Anti-tumor Activity of Elraglusib in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Actuate Therapeutics Inc. 100
Early research (Phase 1)Study completedNCT04341259
What this trial is testing

The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.

Who this might be right for
Solid Tumors
Hoffmann-La Roche 12
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Early research (Phase 1)Study completedNCT05740202
What this trial is testing

A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 22
Testing effectiveness (Phase 2)Looking for participantsNCT07399769
What this trial is testing

Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Shenzhen University General Hospital 20
Early research (Phase 1)Study completedNCT05155722
What this trial is testing

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Bio-Thera Solutions 59
Early research (Phase 1)Study completedNCT03641586
What this trial is testing

The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor

Who this might be right for
Solid Tumors
BeiGene 42
Next Page